ARID3A and liver cancer: Similar to the effects of silencing ARID3A expression, silencing the expression of CEP131 reduced the cell migration, invasion and tumoursphere formation capabilities, while overexpression of CEP131 enhanced these capabilities in liver cancer cells (Fig. 5G–L).